Japanese Medtech Startup, CoreTissue BioEngineering, Becomes First Company Accepted Into Accelerator Program Backed by Mitsubishi Corporation (Americas) and Fogarty Innovation
29 Julio 2024 - 5:00AM
Business Wire
CoreTissue BioEngineering Inc. (“CTBE”), a medical device
start-up developing an artificial ligament derived from
decellularized animal tissue, is the first company to be accepted
by R Accelerator Program, a joint initiative backed by Mitsubishi
Corporation (Americas) (“MCA”) and Fogarty Innovation. This program
is currently focused on helping high-potential Japanese medtech
companies commercialize their products in the U.S. Over the course
of the six-month program, CTBE will work closely with leadership
from MCA and Fogarty Innovation to craft a business development
plan for the U.S. market including regulatory and reimbursement
strategies.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240729905699/en/
Japanese medtech startup, CoreTissue
BioEngineering, becomes first company accepted into accelerator
program backed by Mitsubishi Corporation (Americas) and Fogarty
Innovation (Photo: Business Wire)
More than 800,000 patients worldwide undergo anterior cruciate
ligament (ACL) reconstruction surgery each year including
approximately 20,000 patients in Japan and 200,000 patients in the
U.S. CTBE aims to create better options for patients by developing
an artificial ligament that offers the same biocompatibility and
strength as an autologous transplant without requiring the
patient’s own tissue. The company will start its pivotal clinical
study in Japan later this year.
R Accelerator Program R
Accelerator Program, led by Mitsubishi Corporation (Americas),
helps Japanese startups prepare to enter the U.S. market.
Collaborating with top-tier partners in the innovation ecosystem,
the program provides approximately six months of support in Silicon
Valley, a global hub for innovation and business development.
Comments from program organizers
Mr. Shotaro Wakasa from Mitsubishi
Corporation (Americas) Under the strong leadership of
its CEO, CTBE has crafted a business plan for expanding into the
U.S. market. We are pleased to support the CTBE team as they
develop innovative solutions.
Mr. Mike Regan from Fogarty Innovation,
Chief Innovation Officer We are working closely with the
CTBE team to provide the strategic guidance and regulatory
expertise needed to successfully navigate the complexities of the
U.S. market. We are thrilled to support such an enthusiastic and
motivated team, and we look forward to seeing all that they
accomplish.
Company Overview
CoreTissue BioEngineering Inc.
(CTBE) CTBE is a medical device start-up focusing on the
development of artificial ligaments for Anterior Cruciate Ligament
(ACL) reconstruction surgery through unique decellularization
technology. The company is led by CEO Chiaki Waki, who has nearly
two decades of experience in medtech, including high-level
positions at Abbott, Boston Scientific, and BD. URL:
https://www.coretissue.com/english/
Mitsubishi Corporation
(Americas) Mitsubishi Corporation (Americas) is a wholly
owned subsidiary of Mitsubishi Corporation, a global integrated
business enterprise with eight business groups that operate across
virtually every industry. These include Environmental Energy,
Material Solution, Mineral Resources, Urban Development and
Infrastructure, Mobility, Food Industry, Smart-Life Creation, and
Power Solution. URL:
https://www.mitsubishicorp.com/northamerica/
Fogarty Innovation Fogarty
Innovation is a nonprofit educational medtech incubator dedicated
to advancing human health worldwide. The company’s seasoned
leadership team provides full contact mentoring to help young
companies navigate the path to commercialization, delivers
practical educational programming to stakeholders across the
ecosystem, and forges alliances that accelerate the invention,
development, and deployment of new medical technologies into
clinical care. Founded by Thomas J. Fogarty, MD, a world-renowned
cardiovascular surgeon, inventor, and entrepreneur, Fogarty
Innovation is headquartered on the El Camino Health campus in
Mountain View, California. URL:
https://www.fogartyinnovation.org/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240729905699/en/
CoreTissue BioEngineering Inc. Email: chiaki.waki@coretissue.com
Tel: +81-80-7638-1286